PT  - JOURNAL ARTICLE
AU  - Stamenova, V.
AU  - Chu, C.
AU  - Borgundvaag, E.
AU  - Fleury, C.
AU  - Brual, J.
AU  - Bhattacharyya, O.
AU  - Tadrous, M.
TI  - Virtual care use prior to emergency department admissions during a stable COVID-19 period in Ontario, Canada
AID  - 10.1101/2022.10.20.22281298
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.20.22281298
4099  - http://medrxiv.org/content/early/2022/10/21/2022.10.20.22281298.short
4100  - http://medrxiv.org/content/early/2022/10/21/2022.10.20.22281298.full
AB  - Background The increased use of telemedicine during the pandemic has led to concerns about potential increased emergency department (ED) admissions and outpatient service use prior to such admissions. We examined the frequency of telemedicine use prior to ED admissions and characterized the patients with prior telemedicine use and the physicians who provided these outpatient visits.Methods We conducted a retrospective, population-based, cross-sectional analysis using linked health administrative data in Ontario, Canada to identify patients who had an ED admission between July 1 and September 30, 2021 and patients with an ED admissions during the same period in 2019. We grouped patients based on their use of outpatient services in the 7 days prior to admission and reported their sociodemographic characteristics and healthcare utilization.Results There were 1,080,334 ED admissions in 2021 vs. 1,113,230 in 2019. In 2021, 74% of these admissions had no prior outpatient visits (virtual or in-person) within 7 days of admission, compared to 75% in 2019. Only 3% of ED admissions had both virtual and in-person visits in the 7 days prior to ED admission. Patients with prior virtual care use were more likely to be hospitalized than those without any outpatient care (13% vs 7.7.%).Interpretation The net amount of ED admissions and outpatient care prior to admission remained the same over a period of the COVID-19 pandemic when cases were relatively stable. Virtual care seems to be able to appropriately triage patients to the ED and may even prove beneficial for diverting patients away from the ED when an ED admission is not appropriate.The COVID-19 pandemic has led to the emergence of standard use of telemedicine in health care across the globe(1,2). In Ontario, Canada the proportion of ambulatory visits completed virtually has been maintained at slightly above 50% from 2020 to 2021 (3). Despite its widespread adoption, it is still unclear when virtual visits are clinically appropriate and how such wide use of telemedicine impacts patient outcomes and healthcare utilization metrics.Before the pandemic, there had been concerns that telemedicine may lead to an increased use of outpatient services with patients having both a virtual and an in-person visit for the same clinical issue(4,5). For example, pre-pandemic data (2007-2016) from Manitoba showed that telemedicine users had on average 1.3 times more ambulatory visits than non-users.(6) In addition, studies have produced mixed evidence with regard to the effect of telemedicine on urgent services such as emergency department (ED) admissions and hospitalizations (7). Many of the studies reported in the literature are based on data from site-specific programs and therefore have limited generalizability. Finally, policymakers and some physicians have become concerned that the high rates of telemedicine during COVID-19 have led to an increase in emergency department admissions because of poor access to in-person outpatient care (8). This concern is exacerbated when one considers rural and lower socioeconomic status patients who already had poor access to care before the pandemic(9). Combined with reports of lower uptake of telemedicine among these patients(10,11), it is not clear how the transition of care from in-person to virtual impacts ED use.The high adoption of telemedicine during the pandemic, in the context of a publicly funded healthcare system allowing us access to most visits across the entire population, offers a unique opportunity to examine the frequency of telemedicine use prior to ED admissions. Therefore, the goal of this study was to characterize the frequency and modality (in-person vs virtual) of outpatient care prior to ED admissions. We examined whether there was an overall increase in outpatient visits prior to ED admissions during a period of the pandemic when access to telemedicine was available compared to a seasonality matched period before the pandemic where access to telemedicine was quite limited.We also aimed to characterize the patients who had a telemedicine visit prior to an ED admission vs. those who had an in-person visit and the physicians who saw patients with virtual only visits prior to their ED admission compared to those who saw patients virtually or in-person prior to their ED admission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the Ministry of Health of Ontario, Canada.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Use of these databases for the purposes of this study was authorized under §45 of Ontario’s Personal Health Information Protection Act, which does not require review by a research ethics board (REB). All data was de-identified at ICES and individual patient consent was waived.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is not publicly available and access is limited to the Institute for Clinical Evaluative Sciences (ICES) (https://www.ices.on.ca/), which is a prescribed entity under section 45 of Ontario’s Personal Health Information Protection Act (PHIPA). Researchers, students, policy makers or knowledge users who are affiliated with a publicly funded, not-for-profit organization and who want to obtain and analyze ICES data to answer a research question may submit a request to ICES DAS (https://www.ices.on.ca/DAS/Public-Sector). DAS staff will contact the requestor to discuss the project’s feasibility, timeline and cost. Projects requesting access to data require the approval of a research ethics board. We are happy to share our data creation plan specifying our analyses if you contact the corresponding author and in turn you can use the information in the data creation plan to run the same or follow-up analyses. A list of all datasets used is available in the paper.